Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has responded to a BSE Surveillance Department query regarding unusual movement in the company's share price (Scrip Code: 526445). The company clarified that the price movement is attributable to market reaction from two recent public disclosures: a Rights Issue Committee meeting scheduled for April 9, 2026 to discuss the ongoing Rights Issue process, and a Board Meeting on the same date to consider a potential demerger of the company's food business into a separate entity. The company stated there is no undisclosed material information and that the movement is purely market-driven.
The clarification appears routine and reassuring to investors — the company has confirmed no hidden developments beyond publicly disclosed events. However, the ongoing Rights Issue and potential demerger are material events that shareholders should monitor as they could impact share structure and valuations.